Skip to main content
Clinical Trials/NCT05013073
NCT05013073
Terminated
Not Applicable

Adapting the ASTHMAxcel ED Application to Improve Asthma Related Patient-Centered Outcomes and Health Care Resource Utilization

Montefiore Medical Center2 sites in 1 country160 target enrollmentMay 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
Montefiore Medical Center
Enrollment
160
Locations
2
Primary Endpoint
Asthma Control Test (ACT)
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

This protocol focuses on Phase 1 of a planned two-phase research project. Phase 1 aims to test and adapt a prototype ASTHMAXcelED application for the ED. Phase 2 will be an RCT to test the efficacy of a refined ASTHMAXcelED app after being modified based on the results of Phase 1.

Detailed Description

The original ASTHMAxcel app was developed by Dr. Jariwala, which delivers asthma education and promotes patients' adherence to the national asthma guidelines. The app was developed in accordance with Montefiore Medical Center's regulatory/compliance (determined by the Montefiore Legal department and Einstein-Montefiore Office of Biotechnology) and security (determined by Montefiore IT) policies. Over the last several years the app has been iteratively improved based on patient feedback and has been shown to improve asthma knowledge, asthma control, and asthma-related quality of life among asthma clinic patients. This version of the app has been tailored to the ED, requiring less physician directed education and focusing on common triggers and symptom management. Research associates will ask each patient to download the ASTHMAXcelED app and RA's instruct them on use of the application. RA's will also show every patient a video using the ASTHMAXcelED mobile application in which the investigators demonstrate correct use of an inhaler and discuss asthma triggers.

Registry
clinicaltrials.gov
Start Date
May 1, 2021
End Date
February 7, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • English speakers
  • at least 18+ years old with
  • physician-diagnosed asthma.

Exclusion Criteria

  • severe cognitive or psychiatric conditions precluding capacity to provide informed consent,
  • inability to speak English,
  • lacking the technology to access the app.

Outcomes

Primary Outcomes

Asthma Control Test (ACT)

Time Frame: 4 Week Period

A patient self-administered tool for identifying those with poorly controlled asthma.

Secondary Outcomes

  • mini Asthma Quality of Life Questionnaire (mini AQLQ)(Recall over 2 week period)
  • Unified Theory of Acceptance and use of Technology(Measured at 4 weeks after intervention)

Study Sites (2)

Loading locations...

Similar Trials